SmallCaps
HomeLatest News
Section

Latest News

Breaking news and real-time updates from the ASX small-cap market

dorsaVi Commences Silicon Fabrication of First RRAM-CMOS Validation Chip
Technology

dorsaVi Commences Silicon Fabrication of First RRAM-CMOS Validation Chip

Sports Entertainment Group Strikes Deal to Acquire New Zealand Audio Firm MediaWorks
Industrials & Juniors

Sports Entertainment Group Strikes Deal to Acquire New Zealand Audio Firm MediaWorks

Elixir Energy Launches Strategic Review with Fresh Placement Funding
Energy

Elixir Energy Launches Strategic Review with Fresh Placement Funding

Anteris Technologies Expands PARADIGM Trial as US Recruitment Begins
Biotechnology

Anteris Technologies Expands PARADIGM Trial as US Recruitment Begins

Sierra Nevada Gold Discovers Polymetallic System at As Safra Project in Saudi Arabia
Mining & Resources

Sierra Nevada Gold Discovers Polymetallic System at As Safra Project in Saudi Arabia

Alterity Therapeutics Granted ATH434 Patent to Treat Neurodegenerative Diseases
Biotechnology

Alterity Therapeutics Granted ATH434 Patent to Treat Neurodegenerative Diseases

Kelly Partners Group Lifts Revenue 18% as International Expansion Continues
Industrials & Juniors

Kelly Partners Group Lifts Revenue 18% as International Expansion Continues

Lachlan Star Confirms Emerging High-Grade Gold Discovery at New Waverley Project
Mining & Resources

Lachlan Star Confirms Emerging High-Grade Gold Discovery at New Waverley Project

Sprintex Enters China’s Mechanical Vapor Recompression Market with Jiangsu Bosiwei Partnership
Industrials & Juniors

Sprintex Enters China’s Mechanical Vapor Recompression Market with Jiangsu Bosiwei Partnership

Dreadnought Resources Defines 15km Mangaroon Gold Anomaly as Illaara Pipeline Builds
Mining & Resources

Dreadnought Resources Defines 15km Mangaroon Gold Anomaly as Illaara Pipeline Builds

Red Sky Energy Nears Yarrow Spud as Three-Well Campaign Progresses
Energy

Red Sky Energy Nears Yarrow Spud as Three-Well Campaign Progresses

LTR Pharma Reports 93% SPONTAN Response in Real-World ED Cohort
Biotechnology

LTR Pharma Reports 93% SPONTAN Response in Real-World ED Cohort